Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,898.1
₹57,157 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,091.0
₹38,617 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹528.0
₹8,310 Cr
Pharmaceuticals & Drugs
₹711.7
₹6,452 Cr
Pharmaceuticals & Drugs
₹369.8
₹4,140 Cr
Pharmaceuticals & Drugs
₹372.8
₹3,403 Cr
Pharmaceuticals & Drugs
₹90.4
₹2,322 Cr
Pharmaceuticals & Drugs
₹776.1
₹443 Cr
Pharmaceuticals & Drugs
₹87.1
₹247 Cr
Pharmaceuticals & Drugs
₹32.3
₹157 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,091.0
₹5,453 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹528.0
₹4,257 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹372.8
₹2,522 Cr
Pharmaceuticals & Drugs
₹711.7
₹1,801 Cr
Pharmaceuticals & Drugs
₹369.8
₹746 Cr
Pharmaceuticals & Drugs
₹90.4
₹240 Cr
Pharmaceuticals & Drugs
₹32.3
₹129 Cr
Pharmaceuticals & Drugs
₹26,898.1
₹6,929 Cr
Pharmaceuticals & Drugs
₹776.1
₹323 Cr
Pharmaceuticals & Drugs
₹87.1
₹391 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,091.0
₹1,056 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹528.0
₹325 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹711.7
₹211 Cr
Pharmaceuticals & Drugs
₹372.8
₹202 Cr
Pharmaceuticals & Drugs
₹369.8
₹174 Cr
Pharmaceuticals & Drugs
₹90.4
₹140 Cr
Pharmaceuticals & Drugs
₹32.3
₹5 Cr
Pharmaceuticals & Drugs
₹26,898.1
₹1,552 Cr
Pharmaceuticals & Drugs
₹776.1
₹10 Cr
Pharmaceuticals & Drugs
₹87.1
₹3 Cr

You may also like the below Video Courses